A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2009
11/19/2009	US20090286763 Amino acid derived prodrugs of propofol, compositions and uses thereof
11/19/2009	US20090286762 Pharmaceutical Formulations Comprising Azelastine and a Corticosteroid for the Treatment of Inflammatory or Allergic Conditions
11/19/2009	US20090286761 Anti-Proliferative and Anti-Inflammatory Agent Combination for Treatment of Vascular Disorders with an Implantable Medical Device
11/19/2009	US20090286760 Novel Compositions and Methods for Treating Hyperproliferative Diseases
11/19/2009	US20090286759 Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
11/19/2009	US20090286758 Substituted n-phenyl-5-phenyl-pyrazolin-3-yl amides as cannabinoid receptor antagonists/inverse agonists useful for treating obesity
11/19/2009	US20090286757 Antiviral composition
11/19/2009	US20090286756 Pharmaceutical compositions for use in the treatment of wounds
11/19/2009	US20090286755 Potentiator of radiation therapy
11/19/2009	US20090286754 Method of Treating Cancer and Other Conditions or Disease States Using L-Cytosine Nucleoside Analogs
11/19/2009	US20090286752 Oral formulations of cytidine analogs and methods of use thereof
11/19/2009	US20090286751 Progression inhibitor for disease attributed to abnormal accumulation of liver fat
11/19/2009	US20090286750 Use of ribose in lessening the clinical symptoms of aberrant firing of neurons
11/19/2009	US20090286749 Cosmetic Composition and a Process For Preparing Said Composition
11/19/2009	US20090286743 Methods and Compositions for Treating Conditions of the Eye
11/19/2009	US20090286737 Erbb interface peptidomimetics and methods of use thereof
11/19/2009	US20090286715 Pharmaceutical Composition
11/19/2009	US20090286714 Novel molecules of the card-related protein family and uses thereof
11/19/2009	US20090286316 Nucleic acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer
11/19/2009	US20090285969 Pasteurisation process for microbial cells and microbial oil
11/19/2009	US20090285916 Methods of diagnosis and treatment of equine laminitis and cushing's syndrome
11/19/2009	US20090285911 Cynara scolymus extracts, the use thereof and formulations containing them
11/19/2009	US20090285908 Method of treating endothelial injury
11/19/2009	US20090285905 Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients
11/19/2009	US20090285904 Enhanced antimicrobial activity of plant essential oils
11/19/2009	US20090285902 Dietary supplement composition for blood lipid health
11/19/2009	US20090285900 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
11/19/2009	US20090285899 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a methylxanthine derivative for treatment of asthma or chronic obstructive pulmonary disease
11/19/2009	US20090285898 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
11/19/2009	US20090285897 Rehydratable thiolated polysaccharide particles and sponge
11/19/2009	US20090285893 Treatment of heart failure in women
11/19/2009	US20090285889 Modified release formulations of dihydropyridine compounds and methods of making same
11/19/2009	US20090285888 Derivatives of dihydroxyphenylalanine
11/19/2009	US20090285887 Pharmaceutical Composition Comprising A Plurality of Mini-Tablets Comprising A Factor XA Inhibitor
11/19/2009	US20090285886 Enhanced antimicrobial activity of plant essential oils
11/19/2009	US20090285884 cisplatin derivatives exhibit antitumor cell and/or antiparasitic activity, formed by complexing cisplatin in water and an organic solvent, with a ligand capable of bonding to the platinum of cisplatin and nitrogen dioxide gas; anticarcinogenic agents
11/19/2009	US20090285883 Identification of gastrointestinal, pancreatic and cancer stem cell markers and methods of use thereof
11/19/2009	US20090285881 Cationic lipids and uses thereof
11/19/2009	US20090285878 Compositions and methods for stabilizing liposomal drug formulations
11/19/2009	US20090285877 Percutaneous absorption preparation containing palonosetron
11/19/2009	US20090285873 Implantable medical devices and coatings therefor comprising block copolymers of poly(ethylene glycol) and a poly(lactide-glycolide)
11/19/2009	US20090285865 Palatable, solid oral formulations for male chemical sterilization
11/19/2009	US20090285864 Therapeutic formulation
11/19/2009	US20090285862 Methods and composition for treatment of inflammatory pain
11/19/2009	US20090285850 Oral Carotenoid Supplementation Methods for Improving the Health and Appearance of Skin
11/19/2009	US20090285849 Thiosemicarbazones as anti-virals and immunopotentiators
11/19/2009	US20090285843 Epitope sequences
11/19/2009	US20090285840 Methods for treating pathological neovascularization
11/19/2009	US20090285839 Antigen uptake receptor for candida albicans on dendritic cells
11/19/2009	US20090285836 Use of salinosporamide a to inhibit metastasis
11/19/2009	US20090285832 Methods for treating sunitinib-resistant carcinoma and related biomarkers
11/19/2009	US20090285825 Novel snake toxin
11/19/2009	US20090285819 Methods and compositions for treating influenza
11/19/2009	US20090285817 Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene
11/19/2009	US20090285811 Anti-inflammatory and immunosuppressive glucocorticoid steroids
11/19/2009	US20090285802 Highly concentrated stabilized igm solution
11/19/2009	US20090285800 Aberrant expression of CKS1 and CKS2 and uses thereof
11/19/2009	US20090285797 Use of inhibitors of cyp2a6 for regulating nicotine metabolism
11/19/2009	US20090285796 Mutant jak3 kinase in human leukemia
11/19/2009	US20090285794 Novel non-antibiotic strategy against OGIP infections based on an activated cereal product or ferric quinate
11/19/2009	US20090285792 Compositions and methods for treatment of neovascular diseases
11/19/2009	US20090285791 Regenerating and enhancing development of muscle tissue
11/19/2009	US20090285788 RANDOM RNAi LIBRARIES, METHODS OF GENERATING SAME, AND SCREENING METHODS UTILIZING SAME
11/19/2009	US20090285786 Method to modulate hematopoietic stem cell growth
11/19/2009	US20090285784 DSRNA As Insect Control Agent
11/19/2009	US20090285782 4,6-di- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections
11/19/2009	US20090285778 Use of interleukin-19 to treat cervical cancer
11/19/2009	US20090285777 Uses of Mammalian Cytokine; Related Reagents
11/19/2009	US20090285773 Hepatitis C Virus Inhibitors
11/19/2009	US20090285772 Quinoline derivatives for modulating dna methylation
11/19/2009	US20090285771 Methods and compositions for needleless delivery of macromolecules
11/19/2009	US20090285770 Topical Compositions for Promoting Homeostasis of the Skin
11/19/2009	US20090285766 Photosensitising Composition and Uses Thereof
11/19/2009	US20090285759 Drug, drug guidance system, magnetic detection system, and drug design method
11/19/2009	US20090285750 Agent, composition and method
11/19/2009	DE112007003136T5 Ein Extrakt An extract
11/19/2009	DE102008023801A1 Substituierte Imidazo- und Triazolopyrimidine, Imidazo- und Pyrazolopyrazine und Imidazotriazine Substituted imidazo and triazolopyrimidines, imidazo and Pyrazolopyrazine and imidazotriazines
11/19/2009	DE102008016275A1 Composition, useful e.g. transfection comprises a non-viral gene delivery system containing e.g. cationic lipid, and an agent for partial suppression and/or activation of innate intracellular and/or intercellular immune defense
11/19/2009	CA2761582A1 Oral formulations of cytidine analogs and methods of use thereof
11/19/2009	CA2740029A1 Pharmaceutical composition for treatment of fibromyalgia
11/19/2009	CA2725437A1 Compositions and methods for inhibiting gastric acid secretion
11/19/2009	CA2725416A1 Compounds for improving learning and memory
11/19/2009	CA2725235A1 Sgc stimulators, sgc activators and combinations thereof for the treatment of hearing impairment
11/19/2009	CA2724804A1 Therapy regimen for treating acne related diseases
11/19/2009	CA2724720A1 Immunomodulation by iap inhibitors
11/19/2009	CA2724629A1 Tetrahydrocyclopenta[b]indole androgen receptor modulators
11/19/2009	CA2724522A1 Emollient composition
11/19/2009	CA2724475A1 Genetic alterations on chromosomes 21q, 6q and 15q and methods of use thereof for the diagnosis and treatment of type i diabetes
11/19/2009	CA2724472A1 Micelles for intracellular delivery of therapeutic agents
11/19/2009	CA2724470A1 Maintenance of platelet inhibition during antiplatelet therapy
11/19/2009	CA2724455A1 Polymeric carrier
11/19/2009	CA2724435A1 Selective subtype alpha 2 adrenergic agents and methods for use thereof
11/19/2009	CA2724434A1 Emollient composition for the preventive treatment of atopic dermatitis
11/19/2009	CA2724418A1 Long term disease modification using immunostimulatory oligonucleotides
11/19/2009	CA2724413A1 Compositions and methods relating to heat shock transcription factor activating compounds and targets thereof
11/19/2009	CA2724386A1 Methods and compositions for improving cognitive function
11/19/2009	CA2724332A1 Method of treatment
11/19/2009	CA2724325A1 Combination therapy with an antitumor alkaloid
11/19/2009	CA2724294A1 Glucagon receptor antagonists, compositions, and methods for their use
11/19/2009	CA2724293A1 Quinolynylmethylimidizoles as therapeutic agents

1 ... 2495 2496 2497 2498 2499 2500 2501 2502 2503 2504 2505 2506 2507 2508 2509 2510 2511 2512 2513 2514 2515 ... 7860